Zantac
Zantac (ranitidine) is an H2 blocker that treats and prevents heartburn over the counter and treats and prevents stomach ulcers with a prescription. Zantac’s active ingredient, ranitidine, metabolizes into N-nitrosodimetylamine (NDMA). NDMA is an environmental contaminant that may cause cancer after exposure to high doses over an extended period of time. The FDA has set acceptable levels of NDMA at 96 ng per day, but tests using FDA-approved methods have found that the level of NDMA in Zantac may reach up to 198,000 ng for the standard 150 mg tablets.[1] The FDA announced an immediate recall of all prescription and over-the-counter ranitidine drugs in April 2020 due to potentially unsafe levels of NDMA.[2] Zantac lawsuits claim that the pharmaceutical industry company, Sanofi, knew the potential dangers of NDMA in Zantac but failed to warn the public leading to countless consumers being exposed to high levels of NDMA.
Contact Counsel Hound today for a no-cost consultation and case evaluation if you or a loved one have been diagnosed with cancer after taking Zantac.
Link to Cancer
Symptoms
- Headache
- Fever
- Nausea
- Jaundice
- Vomiting
- Dizziness
- Abdominal cramps
- Enlarged liver
- Reduced function of liver and lungs
Compensation
- If you incurred medical expenses related to the diagnosis and treatment of your disease, we would work to have you reimbursed.
- If the disease forced you to miss work or suffer a wage decrease at a new position, we would prove your losses with timesheets.
- If you lost a loved one to Zantac NDMA exposure, you might be able to recover funeral or burial costs.
Why file a lawsuit?
- Victims of NDMA exposure focus on health and treatment.
- Families afford the cost of their loved one’s medical and funeral expenses.
- Hold manufacturers and companies accountable for NDMA negligence.
- Encourage other victims of Zantac NDMA exposure to seek fair compensation for their injuries.
Zantac Lawsuit Criteria
- Used brand name Zantac OR generic brand (ranitidine) after October 1984 for at least six months.
- Suffered from at least one of the following:
- Bladder Cancer, Breast Cancer, Colorectal Cancer, Esophageal Cancer, Kidney (renal) cancer, Liver Cancer, Lung Cancer, Pancreatic Cancer, Prostate cancer, Stomach Cancer.
- Did not develop an injury as a result of non-qualifying cancer.
- Developed an injury within 12 months after beginning the qualifying medication.
- Diagnosed with an injury within 20 years of the last dose of qualifying medication.
- Aged 69 years or younger if diagnosed with prostate cancer.
- Have not smoked in the past 20 years, if diagnosed with lung cancer.
- Did not live in Michigan, Tennessee, Louisiana, Kentucky, or Puerto Rico while taking qualifying medication.
Qualifying Cancers
- Bladder cancer and Bladder removal
- Colon cancer
- Esophageal cancer
- Liver cancer
- Melanoma
- Ovarian cancer
- Prostate cancer
- Stomach cancer
In Recent News
FAQs
REFERENCES
- https://www.raps.org/news- and-articles/news-articles/2021/2/ analysis-potentially-high- ndma-levels-after-raniti
- https://www.fda.gov/news- events/press-announcements/ fda-requests-removal-all- ranitidine-products-zantac -market
- https://www.atsdr.cdc.gov/ toxprofiles/tp141-c1.pdf
- https://www.epa.gov/sites/ production/files/2014-03/documents/ffrrofactsheet_ contaminant_ndma_january 2014_final.pdf
- https://topclassactions.com/ lawsuit-settlements/prescription/ 1034328-drugmakers-try-to- dodge-medical-monitoring- claims-in-zantac-cancer-lawsuit/
No-Cost Case Evaluation
Law is complicate matter. It can cause you a big problem if you ignore it. Let us help you!
Free Consultation
Law is complicate matter. It can cause you a big problem if you ignore it. Let us help you!